Compare BSX & NTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BSX | NTES |
|---|---|---|
| Founded | 1979 | 1997 |
| Country | United States | China |
| Employees | N/A | 26028 |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.4B | 69.2B |
| IPO Year | 2010 | N/A |
| Metric | BSX | NTES |
|---|---|---|
| Price | $63.44 | $118.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 3 |
| Target Price | $102.10 | ★ $160.00 |
| AVG Volume (30 Days) | ★ 14.5M | 535.5K |
| Earning Date | 04-22-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 2.56% |
| EPS Growth | ★ 55.20 | N/A |
| EPS | ★ 1.94 | N/A |
| Revenue | ★ $9,076,000,000.00 | N/A |
| Revenue This Year | $11.91 | $9.57 |
| Revenue Next Year | $10.26 | $8.57 |
| P/E Ratio | ★ $33.29 | $79.88 |
| Revenue Growth | ★ 12.49 | N/A |
| 52 Week Low | $60.59 | $98.36 |
| 52 Week High | $109.50 | $159.55 |
| Indicator | BSX | NTES |
|---|---|---|
| Relative Strength Index (RSI) | 38.72 | 61.08 |
| Support Level | $60.59 | $111.48 |
| Resistance Level | $76.77 | $119.94 |
| Average True Range (ATR) | 1.80 | 1.85 |
| MACD | 0.46 | 0.85 |
| Stochastic Oscillator | 29.82 | 88.12 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Founded in the late 1990s as an internet portal, NetEase has evolved into China's second-largest online gaming company. Its early success was anchored by the massively multiplayer online role-playing game Fantasy Westward Journey, which laid the foundation for a durable franchise strategy. Over the past decade, the company has expanded its portfolio with successful titles such as Justice, Identity V, Naraka: Bladepoint, and Eggy Party, all of which continue to maintain sizable and engaged player bases.In addition to its in-house development capabilities, NetEase partners with global IP holders such as Microsoft and Marvel to develop and publish titles based on established franchises, including World of Warcraft, Diablo Immortal, and Marvel Rivals, further strengthening its global presence.